Epsilon variant, also known asCAL.20C and referring to two PANGO lineagesB.1.427 andB.1.429, is one of thevariants ofSARS-CoV-2, the virus that causesCOVID-19. It was first detected inCalifornia, USA in July 2020.[1]
As of March 2022, Epsilon is considered as a previously circulating variant of interest by the WHO. It is considered a variant being monitored by the CDC.
The variant has five definingmutations (I4205V and D1183Y in theORF1ab gene, and S13I, W152C,L452R in thespike protein's S-gene),[2] of which the L452R (previously also detected in other unrelated lineages) was of particular concern.[3] B.1.429 is possibly more transmissible than previous variants circulating locally, but further study is necessary to confirm this.[3]Centers for Disease Control and Prevention (CDC) has listed B.1.429 and the related B.1.427 as "variants of concern", and cites apreprint for saying that they exhibit a ~20% increase in viral transmissibility, that they have a "Significant impact onneutralization by some, but not all" therapeutics that have been givenEmergency Use Authorization (EUA) by theFood and Drug Administration (FDA) for treatment or prevention of COVID-19, and that they moderately reduce neutralization by plasma collected by people who have previously been infected by the virus or who have received avaccine against the virus.[4][5] In May 2021, theWorld Health Organization (WHO) gave the variant the name 'Epsilon variant'.[6]
![Amino acid mutations of SARS-CoV-2 Epsilon variant plotted on a genome map of SARS-CoV-2 with a focus on the spike.[7]](/mt/?noimg=&dark=on&url=http%3a%2f%2fen.wikipedia.org%2fwiki%2fFile%3aSARS-CoV-2_Epsilon_variant.svg)
| Part ofa series on the |
| COVID-19 pandemic |
|---|
 |
|
Medical response |
|
.svg) COVID-19 portal |
Epsilon (CAL.20C) was first observed in July 2020 by researchers at theCedars-Sinai Medical Center,California, in one of 1,230 virus samples collected inLos Angeles County from the start of theCOVID-19 epidemic.[1] It was not detected again until September when it reappeared among samples in California, but numbers remained very low until November.[8][9] In November 2020, the Epsilon variant accounted for 36 percent of samples collected at Cedars-Sinai Medical Center, and by January 2021, the Epsilon variant accounted for 50 percent of samples.[3] In a jointpress release byUniversity of California, San Francisco,California Department of Public Health, andSanta Clara County Public Health Department,[10] it was announced that the variant was also detected in multiple counties in Northern California. From November to December 2020, the frequency of the variant in sequenced cases from Northern California rose from 3% to 25%.[11] A preprint describes CAL.20C as belonging toNextstrain clade 20C and contributing approximately 36% of samples, while an emerging variant from the 20G clade accounts for some 24% of the samples in a study focused on Southern California. However, in the US as a whole, the 20G clade predominated as of January 2021. Following the increasing numbers of Epsilon in California, the variant has been detected at varying frequencies in most US states. Small numbers have been detected in other countries in North America, and in Europe, Asia and Australia.[8][9] As of July 2021, the Epsilon variant had been detected in 45 countries, according toGISAID.[12] After an initial increase, its frequency rapidly decreased from February 2021 as it was being outcompeted by the more transmissibleAlpha variant. In April, Epsilon remained relatively frequent in parts of northern California, but it had virtually disappeared from the south of the state and had never been able to establish itself elsewhere; only 3.2% of all cases in the United States were Epsilon, whereas by then more than two-thirds were Alpha.[13]
| Country | Confirmed cases (GISAID)[14] as of 16 January 2024 | Last Reported Case |
|---|---|---|
 USA | 50,723 | 23 June 2021 |
 Mexico | 495 | 8 June 2021 |
 Canada | 385 | 7 May 2021 |
 South Korea | 119 | 26 April 2021 |
 Aruba | 57 | 24 April 2021 |
 Denmark | 37 | 22 March 2021 |
 Maldives | 36 | 7 May 2021 |
 Chile | 30 | 7 June 2021 |
 Argentina | 28 | 12 May 2021 |
 United Kingdom | 25 | 10 May 2021 |
 Japan | 21 | 16 April 2021 |
 Australia | 20 | 12 April 2021 |
 Costa Rica | 12 | 5 May 2021 |
 Germany | 11 | 8 June 2021 |
 Israel | 10 | 25 February 2021 |
 Guam | 8 | 27 March 2021 |
 Taiwan | 8 | 31 January 2021 |
 Guatemala | 7 | |
 France | 7 | 1 March 2021 |
 Ireland | 7 | 28 April 2021 |
 Netherlands | 5 | 10 March 2021 |
 Spain | 5 | 3 June 2021 |
 New Zealand | 4 | 28 December 2020 |
 Singapore | 4 | 27 March 2021 |
 Switzerland | 4 | 1 March 2021 |
 Cameroon | 3 | 5 February 2021 |
| Guadeloupe | 3 | 30 January 2021 |
 Norway | 3 | 12 April 2021 |
 Cambodia | 2 | 20 January 2021 |
 Finland | 2 | 6 February 2021 |
 Italy | 2 | 11 February 2021 |
 Peru | 2 | 24 February 2021 |
 Sweden | 2 | 28 January 2021 |
 Turkey | 2 | 11 February 2021 |
 Turks and Caicos Islands | 2 | 22 March 2021 |
 Colombia | 2 | 8 January 2021 |
 Anguilla | 1 | 19 March 2021 |
 Antigua and Barbuda | 1 | 24 April 2021 |
 Barbados | 1 | 12 April 2021 |
 Belgium | 1 | 18 January 2021 |
 British Virgin Islands | 1 | 7 January 2021 |
 Curacao | 1 | 19 March 2021 |
 India | 1 | 2 March 2021 |
 North Macedonia | 1 | 26 January 2021 |
 Northern Mariana Islands | 1 | 16 January 2021 |
 Sint Maarten | 1 | 16 February 2021 |
 Dominican Republic | 1 | |
| World (46 countries) | Total:51,966 | Total as of 1 July 2021 |
According to GISAID, 45 countries, from US to South Korea, from India to Japan have reported Epsilon variant cases.
